Arsenic trioxide at conventional dosage does not aggravate hemorrhage in the first-line treatment of adult acute promyelocytic leukemia.
Wen CuiJin WangRui-Min NieLing-Ling ZhaoMeng-Qing GaoHong-Ming ZhuLi ChenJiong HuJun-Min LiZhi-Xiang ShenZhen-Yi WangSai-Juan ChenZhu ChenKan-Kan WangXiao-Dong XiJian-Qing MiPublished in: European journal of haematology (2018)
In the first-line treatment of APL, the use of ATO is safe and effective and does not compromise the hemostatic potential that may eventually increase ED rate.